Boston Partners
TRIB

Boston Partners’s Trinity Biotech TRIB Stock Holding History

Boston Partners’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-3,014
Closed -$1.29M – 700
2019
Q1 		$1.29M Sell
3,014
-623
-17% -$257K ﹤0.01% 606
2018
Q4 		$1.25M Sell
3,637
-850
-19% -$394K ﹤0.01% 619
2018
Q3 		$2.69M Sell
4,487
-1,085
-19% -$707K ﹤0.01% 567
2018
Q2 		$4.18M Sell
5,572
-102
-2% -$73.6K 0.01% 493
2018
Q1 		$4.38M Sell
5,674
-1,487
-21% -$1.22M 0.01% 503
2017
Q4 		$5.49M Sell
7,161
-1,138
-14% -$880K 0.01% 477
2017
Q3 		$6.98M Buy
8,299
+540
+7% +$452K 0.01% 449
2017
Q2 		$6.98M Sell
7,759
-963
-11% -$818K 0.01% 428
2017
Q1 		$7.8M Sell
8,722
-1,290
-13% -$1.21M 0.01% 426
2016
Q4 		$10.4M Sell
10,012
-400
-4% -$413K 0.01% 401
2016
Q3 		$20.6M Sell
10,412
-566
-5% -$1.06M 0.03% 317
2016
Q2 		$18.7M Sell
10,978
-65
-0.6% -$110K 0.03% 311
2016
Q1 		$19.3M Buy
11,043
+443
+4% +$705K 0.03% 299
2015
Q4 		$18.7M Buy
10,600
+284
+3% +$503K 0.03% 306
2015
Q3 		$17.7M Buy
10,316
+2,793
+37% +$6.74M 0.03% 308
2015
Q2 		$20.4M Buy
7,523
+1,987
+36% +$5.16M 0.03% 302
2015
Q1 		$16M Buy
5,536
+3,779
+215% +$10.5M 0.02% 338
2014
Q4 		$4.62M Buy
+1,757
New +$4.54M 0.01% 539
2013
Q4 		– Sell
-228
Closed -$743K – 729
2013
Q3 		$743K Sell
228
-740
-76% -$2.16M ﹤0.01% 647
2013
Q2 		$2.45M Buy
+968
New +$2.41M 0.01% 574

Other funds holding TRIB

SCM
Stonehill Capital Management New York $350M AUM 73.6% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $868M AUM 32.25% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $486M AUM 50.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
ARM
Adirondack Research & Management Guilderland, New York $82.2M AUM 63.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Boston Partners's TRIB Position: Q2 2019 in Review

Boston Partners sold out of Trinity Biotech (TRIB) in Q2 2019, closing a stake of 3,014 shares — an estimated $1.29M sold.

Boston Partners first reported a position in TRIB in Q2 2013 and held it in 20 quarters. The position peaked at $20.6M in Q3 2016. 34 funds tracked by Wall St. Rank hold TRIB as of Q2 2019.

  • Boston Partners reported no remaining Trinity Biotech position as of Q2 2019 after selling out during the quarter.
  • Boston Partners sold 3,014 Trinity Biotech shares in Q2 2019, an estimated $1.29M.
  • Boston Partners first reported a position in Trinity Biotech in Q2 2013 and held it in 20 quarters.
  • Boston Partners's Trinity Biotech position peaked at $20.6M in Q3 2016.
  • 34 funds tracked by Wall St. Rank held Trinity Biotech as of Q2 2019.

Based on Boston Partners's 13F filing for Q2 2019, filed 9 Aug 2019.